Effect of Andecaliximab on FEV1 in Adults With Cystic Fibrosis
Clinical trial NCT02759562 · TERMINATED
Trial details
- NCT number
- NCT02759562
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-04
- Primary completion
- 2017-07-06
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.